ROMEO, MARIO
 Distribuzione geografica
Continente #
EU - Europa 504
NA - Nord America 453
AS - Asia 122
SA - Sud America 4
AF - Africa 1
Totale 1.084
Nazione #
US - Stati Uniti d'America 451
IT - Italia 234
IE - Irlanda 172
SG - Singapore 71
CN - Cina 31
DE - Germania 24
GB - Regno Unito 16
NL - Olanda 14
FR - Francia 13
KR - Corea 9
AT - Austria 7
FI - Finlandia 5
GR - Grecia 5
HK - Hong Kong 4
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
SE - Svezia 3
BE - Belgio 2
CA - Canada 2
IN - India 2
JP - Giappone 2
MK - Macedonia 2
PE - Perù 2
AR - Argentina 1
BO - Bolivia 1
EG - Egitto 1
KG - Kirghizistan 1
KZ - Kazakistan 1
PK - Pakistan 1
Totale 1.084
Città #
Dublin 170
Santa Clara 127
Naples 66
Chandler 59
Singapore 50
New York 33
Boardman 24
Ashburn 21
Beijing 16
Boydton 13
Bremen 13
Amsterdam 12
Princeton 11
Roxbury 10
Cambridge 9
Paris 9
Salerno 9
Seoul 9
Rome 8
Aversa 7
Munich 7
Sennori 6
Vienna 6
Des Moines 5
Cesa 4
Lappeenranta 4
Los Angeles 4
Bisaccia 3
Caserta 3
Jacksonville 3
Medford 3
Milan 3
Zola Predosa 3
Arnhem 2
Atlanta 2
Brno 2
Brussels 2
Buffalo 2
Casoria 2
Catania 2
Clifton 2
Forlì 2
Hong Kong 2
Lima 2
Nerviano 2
Pagani 2
Pavia 2
Pozzuoli 2
Pune 2
San Giovanni Lupatoto 2
Verona 2
Wilmington 2
Almaty 1
Ann Arbor 1
Bacoli 1
Bishkek 1
Brdo 1
Brusciano 1
Cairo 1
Castellammare di Stabia 1
Cellole 1
Central 1
Ercolano 1
Fairfield 1
Ferrara 1
Frankfurt am Main 1
Gallarate 1
Hackney 1
Helsinki 1
Houston 1
Jiaxing 1
Jinan 1
La Paz 1
London 1
Maletto 1
Moscow 1
Newark 1
Nola 1
North Bergen 1
Norwalk 1
Nuremberg 1
Ottaviano 1
Ottawa 1
Pomezia 1
Pompei 1
Quarto 1
Ronchis 1
San Marcellino 1
Santa Maria Capua Vetere 1
Secaucus 1
Shanghai 1
Shenzhen 1
St Petersburg 1
Stockholm 1
Thessaloniki 1
Trentola-Ducenta 1
Villa Carlos Paz 1
Yekaterinburg 1
Zhengzhou 1
Totale 815
Nome #
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 77
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 69
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 63
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 62
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 62
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 54
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 51
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 46
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 44
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 43
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 41
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 34
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 34
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 33
Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study 32
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 31
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 30
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 30
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 29
INTESTINAL MICROBIOTA, INTESTINAL PERMEABILITY AND THE UROGENITAL TRACT: IS THERE A PATHOPHYSIOLOGICAL LINK? 26
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 25
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 23
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 23
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 19
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 17
Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic 15
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study 14
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 14
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 14
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 12
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 12
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 12
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future? 11
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider? 11
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 10
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 9
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study 8
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report 7
Totale 1.147
Categoria #
all - tutte 7.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 1 2 0 0 1 2 1
2020/202161 4 0 0 2 5 2 6 3 7 10 17 5
2021/2022110 0 6 6 14 15 9 1 0 5 4 27 23
2022/2023348 17 9 6 20 75 17 2 14 156 9 13 10
2023/2024323 19 11 24 29 55 58 9 9 5 10 31 63
2024/2025297 22 16 16 38 119 86 0 0 0 0 0 0
Totale 1.147